A series of time domain nonlinear and frequency domain equivalent-linear ground response analysis was conducted for a representative site in Ottawa, Canada. The objective is to provide insight into the performance of different site response analysis approaches in predicting site amplification factors for the soft soil deposit over a wide range of shear strain. The surficial geology of the site is predominantly composed of the sensitive Leda Clay typical of this region in eastern Canada. A combination of results and observations from monotonic and cyclic laboratory tests, as well as field geophysical experiments, was used to calibrate the dynamic properties of the Leda clay, more specifically, the variation of the clay's shear stiffness (G max ) with the in situ stress state (r 0 vc ; OCR). The calibrated relation was then successfully validated through materialspecific site response analysis using the strong motion recordings from the 2010 Val-desBois earthquake and the shear wave velocity profile from borehole data. Comparison of the results with the hazard spectra proposed by NBCC 2010 reveals that the code-based site class E hazard spectra for the Ottawa area can be sufficient for seismic design, except around the natural site period. The results also suggest that the nonlinear analysis using the shear strength-adjusted hyperbola for modulus reduction and best-fitting trend to the laboratorybased damping would provide a reliable estimation of ground motion spectra at the natural site period. The performance of the ground response analysis alternatives for the sensitive clays, over a wide strain range was compared and discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.